These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 21470026
1. Preexposure chemoprophylaxis for HIV prevention. Lee DH, Vielemeyer O. N Engl J Med; 2011 Apr 07; 364(14):1372-3; author reply 1374-5. PubMed ID: 21470026 [No Abstract] [Full Text] [Related]
6. Systemic preexposure prophylaxis for HIV: translating clinical data to clinical practice. Li J, Dufrene SL, Okulicz JF. Ann Pharmacother; 2014 Apr 07; 48(4):507-18. PubMed ID: 24473492 [Abstract] [Full Text] [Related]
7. The price of tenofovir-emtricitabine undermines the cost-effectiveness and advancement of pre-exposure prophylaxis. Keller SB, Smith DM. AIDS; 2011 Nov 28; 25(18):2308-10. PubMed ID: 22067201 [No Abstract] [Full Text] [Related]
8. HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness. Paltiel AD, Freedberg KA, Scott CA, Schackman BR, Losina E, Wang B, Seage GR, Sloan CE, Sax PE, Walensky RP. Clin Infect Dis; 2009 Mar 15; 48(6):806-15. PubMed ID: 19193111 [Abstract] [Full Text] [Related]
9. HIV-serodiscordant couples desiring a child: 'treatment as prevention,' preexposure prophylaxis, or medically assisted procreation? Mabileau G, Schwarzinger M, Flores J, Patrat C, Luton D, Epelboin S, Mandelbrot L, Matheron S, Yazdanpanah Y. Am J Obstet Gynecol; 2015 Sep 15; 213(3):341.e1-12. PubMed ID: 25979615 [Abstract] [Full Text] [Related]
10. ACOG Committee Opinion no 595: Committee on Gynecologic Practice: Preexposure prophylaxis for the prevention of human immunodeficiency virus. Obstet Gynecol; 2014 May 15; 123(5):1133-1136. PubMed ID: 24785877 [Abstract] [Full Text] [Related]
11. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapía M, Guanira-Carranza JV, Ramirez-Cardich ME, Montoya-Herrera O, Fernández T, Veloso VG, Buchbinder SP, Chariyalertsak S, Schechter M, Bekker LG, Mayer KH, Kallás EG, Amico KR, Mulligan K, Bushman LR, Hance RJ, Ganoza C, Defechereux P, Postle B, Wang F, McConnell JJ, Zheng JH, Lee J, Rooney JF, Jaffe HS, Martinez AI, Burns DN, Glidden DV, iPrEx Study Team. N Engl J Med; 2010 Dec 30; 363(27):2587-99. PubMed ID: 21091279 [Abstract] [Full Text] [Related]
12. Integrating HIV prevention into practice. Mathers BM, Cooper DA. JAMA; 2010 Dec 30; 312(4):349-50. PubMed ID: 25038352 [No Abstract] [Full Text] [Related]
13. When is good good enough for HIV-1 prophylaxis? Buchbinder S. Lancet Infect Dis; 2014 Nov 30; 14(11):1024-1025. PubMed ID: 25300861 [No Abstract] [Full Text] [Related]
14. Cost-effectiveness analysis of emtricitabine/tenofovir versus lamivudine/zidovudine, in combination with efavirenz, in antiretroviral-naive, HIV-1-infected patients. Sánchez-de la Rosa R, Herrera L, Moreno S. Clin Ther; 2008 Feb 30; 30(2):372-81. PubMed ID: 18343275 [Abstract] [Full Text] [Related]
18. Re.: Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. Berger RE. J Urol; 2011 May 30; 185(5):1729-30. PubMed ID: 22088703 [No Abstract] [Full Text] [Related]
19. Preexposure prophylaxis for HIV--where do we go from here? Cohen MS, Baden LR. N Engl J Med; 2012 Aug 02; 367(5):459-61. PubMed ID: 22784041 [No Abstract] [Full Text] [Related]